U.S. pharma giant copyright scrapped two experimental weight loss pills final year—a after-daily tablet, lotiglipron, on account of elevated liver enzymes along with a twice-each day capsule, danuglipron, because of robust Unwanted side effects—but CEO Albert Bourla has stated the company is determined to “Perform and gain” during the obesi… Read More